Dr. Sherman Holtan, MD
Claim this profileClinical Trials Sherman Holtan, MD is currently running
More about Sherman Holtan, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Sherman Holtan, MD has experience with
- Corticosteroids
- HCG
- Ruxolitinib 10 MG Oral Tablet
Breakdown of trials Sherman Holtan, MD has run
Graft-versus-Host Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sherman Holtan, MD specialize in?
Sherman Holtan, MD focuses on Graft-versus-Host Disease and other conditions. In particular, much of their work with Graft-versus-Host Disease has involved treating patients, or patients who are undergoing treatment.
Is Sherman Holtan, MD currently recruiting for clinical trials?
Yes, Sherman Holtan, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Sherman Holtan, MD has studied deeply?
Yes, Sherman Holtan, MD has studied treatments such as Corticosteroids, hCG, Ruxolitinib 10 MG Oral Tablet.
What is the best way to schedule an appointment with Sherman Holtan, MD?
Apply for one of the trials that Sherman Holtan, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.